EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Assessing Extracellular Vesicle Turnover In Vivo Using Highly Sensitive Phosphatidylserine‐Binding Reagents

Lavinia Flaskamp, Monica Prechtl, Annkathrin Scheck, Wenbo Hu, Christine Ried, Georg Kislinger, Mikael Simons, Anne B Krug, Jan Kranich, Thomas Brocker iD

Advanced Science · 2025

DOI: 10.1002/advs.202507624 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Lavinia Flaskamp und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Immunology, Faculty of Medicine, BMC, LMU Munich, Großhaderner Strasse 9, 82152, Planegg, Germany. Hauptthemen laut MEDLINE: Extracellular Vesicles, Phosphatidylserines. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft (German Research Foundation), European Union, European Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Extracellular vesicles (EVs) are emerging as crucial players in cell communication and hold great promise as biomarkers and therapeutic tools. However, their diversity makes it challenging to detect, classify, and utilize them effectively, which limits their clinical applicability. A key challenge is the lack of reliable markers to identify EVs consistently. In this study, a novel high‐affinity phosphatidylserine (PS)‐binding reagent is introduced for EV analysis. PS is known as a marker of apoptotic cells and activated platelets, but its presence on EVs is debated due to variations in lipid composition. By comparing multiple PS‐binding reagents, including MFG‐E8 derivatives and Annexin V, it is demonstrated that ≈90% of EVs in human and mouse blood carry PS. Using the optimized reagent, the first in vivo insights into EV turnover are provided, showing that PS+ EVs in mouse blood are rapidly cleared (≈50% within 30 min) but persist on immune cells in the spleen. This discovery increases the potential of EVs as disease biomarkers and therapeutic targets by improving EV detection and isolation as well as opening the door for standardized quantification and diagnostic monitoring.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Extracellular VesiclesPhosphatidylserinesAnimalsMiceHumansBiomarkersMice, Inbred C57BLAnnexin A5

Stichwörter der Autor:innen

EV‐turnoverMFG‐E8extracellular Vesicles (EVs)lactadherinphosphatidylserine (PS)

Substanzen

PhosphatidylserinesBiomarkersAnnexin A5

Autor:innen und Institutionen

  • Institute for Immunology, Faculty of Medicine, BMC, LMU Munich, Großhaderner Strasse 9, 82152, Planegg, Germany.
  • German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.

ORCID-Profile: Thomas Brocker

Förderung

  • Deutsche Forschungsgemeinschaft (German Research Foundation)
  • European Union
  • European Commission

Zitieren

APA

Flaskamp, L., Prechtl, M., Scheck, A., Hu, W., Ried, C., Kislinger, G., Simons, M., Krug, A. B., Kranich, J., & Brocker, T. (2025). Assessing Extracellular Vesicle Turnover In Vivo Using Highly Sensitive Phosphatidylserine‐Binding Reagents. Advanced Science. https://doi.org/10.1002/advs.202507624

Vancouver

Flaskamp L, Prechtl M, Scheck A, Hu W, Ried C, Kislinger G, et al. Assessing Extracellular Vesicle Turnover In Vivo Using Highly Sensitive Phosphatidylserine‐Binding Reagents. Advanced Science. 2025. doi:10.1002/advs.202507624

BibTeX
@article{Flaskamp2025,
  author = {Flaskamp, Lavinia and Prechtl, Monica and Scheck, Annkathrin and Hu, Wenbo and Ried, Christine and Kislinger, Georg and Simons, Mikael and Krug, Anne B and Kranich, Jan and Brocker, Thomas},
  title = {Assessing Extracellular Vesicle Turnover In Vivo Using Highly Sensitive Phosphatidylserine‐Binding Reagents},
  journal = {Advanced Science},
  year = {2025},
  doi = {10.1002/advs.202507624}
}
Kostenlos starten →